Clolar and Nausea - a phase IV clinical study of FDA data

Summary:

Nausea is reported as a side effect among people who take Clolar (clofarabine), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Lorazepam, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Nausea when taking Clolar. It is created by eHealthMe based on reports of 1,091 people who have side effects when taking Clolar from the FDA, and is updated regularly.

What is Clolar?

Clolar has active ingredients of clofarabine. eHealthMe is studying from 1,093 Clolar users. Check the latest studies of Clolar.

What is Nausea?

Nausea (feeling of having an urge to vomit) is found to be associated with 3,877 drugs and 5,632 conditions by eHealthMe. Check the latest studies of Nausea.

On Jul, 06, 2026

1,091 people reported to have side effects when taking Clolar.
Among them, 50 people (4.58%) have Nausea.

Among these 50 people:

How long have people been on Clolar when they have Nausea? *

What is the gender of people who have Nausea when taking Clolar? *

female: 57.45 %
male: 42.55 %

What is the age of people who have Nausea when taking Clolar? *

What are other drugs people take besides Clolar? *

What are other side effects people have besides Nausea? *

Nausea And Vomiting: 34 people, 68.00%
Fever: 14 people, 28.00%
Hypotension (abnormally low blood pressure): 13 people, 26.00%
Diarrhea: 13 people, 26.00%
Thrombocytopenia (decrease of platelets in blood): 12 people, 24.00%
Acute Kidney Failure: 11 people, 22.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 11 people, 22.00%
Febrile Neutropenia (fever with reduced white blood cells): 10 people, 20.00%
Pain In Extremity: 9 people, 18.00%
Enlarged Heart: 8 people, 16.00%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 12 people, 24.00%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 18.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 12.00%
Bone Marrow Conditioning Regimen: 4 people, 8.00%
Acute Leukaemia (blood cancer): 4 people, 8.00%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 3 people, 6.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 6.00%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 2 people, 4.00%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 2 people, 4.00%
Stress And Anxiety: 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clolar and have Nausea?

- Check whether Nausea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clolar:

Clolar (1,093 reports)

Nausea treatments and more:

Nausea (962,089 reports)

Browse all side effects of Clolar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea:

Nausea (3,877 drugs)

Browse all the conditions that are associated with Nausea:

Nausea (5,632 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clofarabine (the active ingredients of Clolar) and Clolar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.